Ruxience
Payments companies reported to CMS as associated with Ruxience. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ruxience, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ruxience
These are the largest totals companies reported as associated with Ruxience. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kin Lam | New York, NY | Internal Medicine | $31.85 |
| Zhao Lu | Milford, CT | Hematology & Oncology | $29.88 |
| Paul Bader | Rego Park, NY | Hematology & Oncology | $24.74 |
| Jeffrey Ambinder | Yorktown Heights, NY | Hematology & Oncology | $23.87 |
| Howard Zipin | Sellersville, PA | Hematology & Oncology | $21.42 |
| Geeta George | Peekskill, NY | Hematology & Oncology | $20.14 |
| Seth Benkel | New City, NY | Hematology & Oncology | $18.79 |
| Sara Martos | Suffern, NY | Physician Assistant | $18.79 |
| Ian Hantman | New Rochelle, NY | Hematology & Oncology | $16.40 |
| Susan Harrison | Belleville, NJ | Nurse Practitioner | $16.04 |
Prescribed Ruxience?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.